High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma. This evidence concerns the gene HMMR and head and neck squamous cell carcinoma.